FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103018173> ?p ?o ?g. }

• W2103018173 endingPage "S368" @default.
• W2103018173 startingPage "S368" @default.
• W2103018173 abstract "Purpose/Objective(s)Hepatocellular carcinoma (HCC) is commonly associated with cirrhosis. Radiation therapy (RT) is a treatment of choice in patient with a large tumor burden, or portal vein tumor thrombosis. To avoid early deterioration of liver function (EDLF), selection of patient for hepatic RT is imperative. This study was to compare the predictive ability of various pretreatment scoring systems including Child-Turcotte-Pugh (CTP) score, Model for End-Stage Liver Disease (MELD) score, staging systems for TNM seventh edition, Barcelona Clinic Liver Cancer (BCLC), and Cancer of the Liver Italian Program (CLIP).Materials/MethodsBetween January 2010 and August 2013, 103 consecutive patients diagnosed with advanced HCC and receiving hepatic RT were included for this retrospective analysis. Eighty-six (83.5%) had chronic hepatitis B or C virus-related HCC. The majority of patients were BCLC stage C (A-5, B-11, C-82, D-5) and CTP score A (A-68, B-31, C-4). Portal vein thrombosis was found in 83 patients. The EDLF was defined as any event of grade 3 or above liver toxicities occurring within 2 months after the commencement of RT. The surveillance markers for the EDLF included serum bilirubin, aspartate aminotransferase/alanine aminotransferase, and albumin. The toxicities were graded according to the Common Terminology Criteria for adverse events Version 4. The data of dose-volume histogram (DVH) were also retrieved for the analysis. Logistic regression analysis was used to recognize the predictors of the EDLF. Prognosticators for survival were identified by Cox regression analysis.ResultsThe median follow-up of alive patients was 9 months. 30 patients (29.1%) developed the EDLF. MELD score > 10 is the predictor for the EDLF (Odds ratio 4.67, 95% confidence interval 1.87-11.51, p = 0.001). The incidence in patients with MELD score > 10 and ≦10 was 47.6% and 16.4%, respectively. The parameters of DVH were not associated with the EDLF. MELD score > 10 and CLIP score > 2 were two prognostic factors associated with inferior overall survival (Hazard ratio 1.930, p = 0.011; Hazard ratio 3.984, p < 0.001, respectively). Patients with MELD score > 10 had a lower median survival compared to those with MELD score ≦ 10 (4 months vs 9 months). The median survival for patients with CLIP score > 2 and ≦ 2 were 3 months and 14 months, respectively.ConclusionsTo optimize case selection for patients with advanced HCC requiring RT, MELD score > 10 is the most informative scoring systems in predicting the EDLF. Together with CLIP score, MELD score can be also used for predicting overall survival. Purpose/Objective(s)Hepatocellular carcinoma (HCC) is commonly associated with cirrhosis. Radiation therapy (RT) is a treatment of choice in patient with a large tumor burden, or portal vein tumor thrombosis. To avoid early deterioration of liver function (EDLF), selection of patient for hepatic RT is imperative. This study was to compare the predictive ability of various pretreatment scoring systems including Child-Turcotte-Pugh (CTP) score, Model for End-Stage Liver Disease (MELD) score, staging systems for TNM seventh edition, Barcelona Clinic Liver Cancer (BCLC), and Cancer of the Liver Italian Program (CLIP). Hepatocellular carcinoma (HCC) is commonly associated with cirrhosis. Radiation therapy (RT) is a treatment of choice in patient with a large tumor burden, or portal vein tumor thrombosis. To avoid early deterioration of liver function (EDLF), selection of patient for hepatic RT is imperative. This study was to compare the predictive ability of various pretreatment scoring systems including Child-Turcotte-Pugh (CTP) score, Model for End-Stage Liver Disease (MELD) score, staging systems for TNM seventh edition, Barcelona Clinic Liver Cancer (BCLC), and Cancer of the Liver Italian Program (CLIP). Materials/MethodsBetween January 2010 and August 2013, 103 consecutive patients diagnosed with advanced HCC and receiving hepatic RT were included for this retrospective analysis. Eighty-six (83.5%) had chronic hepatitis B or C virus-related HCC. The majority of patients were BCLC stage C (A-5, B-11, C-82, D-5) and CTP score A (A-68, B-31, C-4). Portal vein thrombosis was found in 83 patients. The EDLF was defined as any event of grade 3 or above liver toxicities occurring within 2 months after the commencement of RT. The surveillance markers for the EDLF included serum bilirubin, aspartate aminotransferase/alanine aminotransferase, and albumin. The toxicities were graded according to the Common Terminology Criteria for adverse events Version 4. The data of dose-volume histogram (DVH) were also retrieved for the analysis. Logistic regression analysis was used to recognize the predictors of the EDLF. Prognosticators for survival were identified by Cox regression analysis. Between January 2010 and August 2013, 103 consecutive patients diagnosed with advanced HCC and receiving hepatic RT were included for this retrospective analysis. Eighty-six (83.5%) had chronic hepatitis B or C virus-related HCC. The majority of patients were BCLC stage C (A-5, B-11, C-82, D-5) and CTP score A (A-68, B-31, C-4). Portal vein thrombosis was found in 83 patients. The EDLF was defined as any event of grade 3 or above liver toxicities occurring within 2 months after the commencement of RT. The surveillance markers for the EDLF included serum bilirubin, aspartate aminotransferase/alanine aminotransferase, and albumin. The toxicities were graded according to the Common Terminology Criteria for adverse events Version 4. The data of dose-volume histogram (DVH) were also retrieved for the analysis. Logistic regression analysis was used to recognize the predictors of the EDLF. Prognosticators for survival were identified by Cox regression analysis. ResultsThe median follow-up of alive patients was 9 months. 30 patients (29.1%) developed the EDLF. MELD score > 10 is the predictor for the EDLF (Odds ratio 4.67, 95% confidence interval 1.87-11.51, p = 0.001). The incidence in patients with MELD score > 10 and ≦10 was 47.6% and 16.4%, respectively. The parameters of DVH were not associated with the EDLF. MELD score > 10 and CLIP score > 2 were two prognostic factors associated with inferior overall survival (Hazard ratio 1.930, p = 0.011; Hazard ratio 3.984, p < 0.001, respectively). Patients with MELD score > 10 had a lower median survival compared to those with MELD score ≦ 10 (4 months vs 9 months). The median survival for patients with CLIP score > 2 and ≦ 2 were 3 months and 14 months, respectively. The median follow-up of alive patients was 9 months. 30 patients (29.1%) developed the EDLF. MELD score > 10 is the predictor for the EDLF (Odds ratio 4.67, 95% confidence interval 1.87-11.51, p = 0.001). The incidence in patients with MELD score > 10 and ≦10 was 47.6% and 16.4%, respectively. The parameters of DVH were not associated with the EDLF. MELD score > 10 and CLIP score > 2 were two prognostic factors associated with inferior overall survival (Hazard ratio 1.930, p = 0.011; Hazard ratio 3.984, p < 0.001, respectively). Patients with MELD score > 10 had a lower median survival compared to those with MELD score ≦ 10 (4 months vs 9 months). The median survival for patients with CLIP score > 2 and ≦ 2 were 3 months and 14 months, respectively. ConclusionsTo optimize case selection for patients with advanced HCC requiring RT, MELD score > 10 is the most informative scoring systems in predicting the EDLF. Together with CLIP score, MELD score can be also used for predicting overall survival. To optimize case selection for patients with advanced HCC requiring RT, MELD score > 10 is the most informative scoring systems in predicting the EDLF. Together with CLIP score, MELD score can be also used for predicting overall survival." @default.
• W2103018173 created "2016-06-24" @default.
• W2103018173 creator A5022072240 @default.
• W2103018173 creator A5056110673 @default.
• W2103018173 creator A5060410823 @default.
• W2103018173 creator A5060515281 @default.
• W2103018173 creator A5091509935 @default.
• W2103018173 date "2014-09-01" @default.
• W2103018173 modified "2023-09-26" @default.
• W2103018173 title "MELD Score Is a Predictor of Early Deterioration of Liver Function and Overall Survival in Patients With Hepatocellular Carcinoma Receiving Radiation Therapy" @default.
• W2103018173 doi "https://doi.org/10.1016/j.ijrobp.2014.05.1189" @default.
• W2103018173 hasPublicationYear "2014" @default.
• W2103018173 type Work @default.
• W2103018173 sameAs 2103018173 @default.
• W2103018173 citedByCount "0" @default.
• W2103018173 crossrefType "journal-article" @default.
• W2103018173 hasAuthorship W2103018173A5022072240 @default.
• W2103018173 hasAuthorship W2103018173A5056110673 @default.
• W2103018173 hasAuthorship W2103018173A5060410823 @default.
• W2103018173 hasAuthorship W2103018173A5060515281 @default.
• W2103018173 hasAuthorship W2103018173A5091509935 @default.
• W2103018173 hasConcept C126322002 @default.
• W2103018173 hasConcept C143998085 @default.
• W2103018173 hasConcept C2778019345 @default.
• W2103018173 hasConcept C2992208098 @default.
• W2103018173 hasConcept C3019894029 @default.
• W2103018173 hasConcept C509974204 @default.
• W2103018173 hasConcept C71924100 @default.
• W2103018173 hasConcept C90924648 @default.
• W2103018173 hasConceptScore W2103018173C126322002 @default.
• W2103018173 hasConceptScore W2103018173C143998085 @default.
• W2103018173 hasConceptScore W2103018173C2778019345 @default.
• W2103018173 hasConceptScore W2103018173C2992208098 @default.
• W2103018173 hasConceptScore W2103018173C3019894029 @default.
• W2103018173 hasConceptScore W2103018173C509974204 @default.
• W2103018173 hasConceptScore W2103018173C71924100 @default.
• W2103018173 hasConceptScore W2103018173C90924648 @default.
• W2103018173 hasIssue "1" @default.
• W2103018173 hasLocation W21030181731 @default.
• W2103018173 hasOpenAccess W2103018173 @default.
• W2103018173 hasPrimaryLocation W21030181731 @default.
• W2103018173 hasRelatedWork W14759935 @default.
• W2103018173 hasRelatedWork W1985624846 @default.
• W2103018173 hasRelatedWork W1990410823 @default.
• W2103018173 hasRelatedWork W2046338614 @default.
• W2103018173 hasRelatedWork W2064648005 @default.
• W2103018173 hasRelatedWork W2315696788 @default.
• W2103018173 hasRelatedWork W2347335137 @default.
• W2103018173 hasRelatedWork W2803786348 @default.
• W2103018173 hasRelatedWork W4225706871 @default.
• W2103018173 hasRelatedWork W4250185241 @default.
• W2103018173 hasVolume "90" @default.
• W2103018173 isParatext "false" @default.
• W2103018173 isRetracted "false" @default.
• W2103018173 magId "2103018173" @default.
• W2103018173 workType "article" @default.